ClinicalTrials.Veeva

Menu

Comparison of the Effect on Anxiety of Combining Hypnosis and Aromatherapy Through Olfactory Anchoring Versus Standard Care in Patients Undergoing Alcohol Withdrawal (ASHA)

U

University Hospital, Strasbourg, France

Status

Not yet enrolling

Conditions

Alcohol Withdrawal
Anxiety

Treatments

Other: Usual treatment
Other: Experimental treatment

Study type

Interventional

Funder types

Other

Identifiers

NCT07444255
RC25-0040

Details and patient eligibility

About

According to a meta-analysis published in 2019, hypnosis has demonstrated positive effects in the treatment of certain mental illnesses, particularly anxiety. This technique aims to put the subject into a particular state of consciousness conducive to therapeutic action. The safe place in hypnosis is the basis for anxiety relief work, the first step towards the use of hypnotic metaphors. Smell is an excellent way to stimulate the imagination in creating this safe place.

Anchoring allows the effects of a hypnosis session to be reactivated, enabling the subject to re-experience its benefits through tactile stimulation, a key word, or an image. The investigators use olfactory stimulation as a hypnotic anchor while also utilizing the anxiolytic properties of essential oils.

While there are already studies on the use of hypnosis or aromatherapy in the treatment of patients who use psychotropic drugs, no study to date has focused on their combined use. The innovative aspect of this treatment lies in the prolongation and reinforcement of the effect of the hypnosis session through olfactory stimulation.

The literature shows that memories triggered by a smell have the ability to materialize physiologically in the areas of the brain that process spatial and temporal information. This is also a goal that hypnosis aspires to achieve.

The investigators hypothesize that the use of these two tools in formalized, time-limited nursing interviews can provide patients in the complex withdrawal unit with the means to reduce their anxiety in the short and medium term.

Enrollment

80 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged 18 or over
  • Patients hospitalized in an addiction unit for acute alcohol withdrawal and suffering from anxiety disorders
  • Patients affiliated with a social security health insurance scheme, beneficiaries or dependents
  • Patients who speak/read French, are able to understand the objectives and risks associated with the research, and can give dated and signed informed consent
  • Patients who adhere to complementary therapies
  • For women of childbearing age, patients for whom the beta HCG test (urine or blood, performed routinely) is negative and who are using effective contraception.

Exclusion criteria

  • Allergy(ies)/contraindication(s) to essential oils selected for the project
  • Patients with psychosis or complex psychological trauma
  • Anosmia, hyposmia, or other olfactory disorders limiting the quality of smell
  • Asthma
  • Ear, nose and throat pathology(ies) contraindicating essential oils in olfaction
  • Skepticism regarding the effectiveness of hypnosis and aromatherapy
  • Patient under guardianship/curatorship
  • Patients excluded from a previous or ongoing study
  • Patients in an emergency or life-threatening situation
  • Patients under legal guardianship
  • Patients who have already participated in this study
  • Pregnancy
  • Breastfeeding

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

80 participants in 2 patient groups

Patients Undergoing Alcohol Withdrawal treated by usual treatment
Active Comparator group
Treatment:
Other: Usual treatment
Patients Undergoing Alcohol Withdrawal treated with Hypnosis and Aromatherapy
Experimental group
Treatment:
Other: Experimental treatment

Trial contacts and locations

1

Loading...

Central trial contact

Benoît Lefeuvre

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems